Paper Details
- Home
- Paper Details
Quantification of Hydrochlorothiazide and Ramipril/Ramiprilate in Blood Serum and Cerebrospinal Fluid: A Pharmacokinetic Assessment of Central Nervous System Adverse Effects.
Author: FuhrUwe, HolzgrabeUlrike, KinzigMartina, SchroeterMichael, SigaroudiAli, StelzerChristoph, SörgelFritz, WahlOliver
Original Abstract of the Article :
A drug must reach the central nervous system (CNS) in order to directly cause CNS adverse effects (AEs). Our current study addressed the pharmacokinetic (PK) background of the assumption that CNS concentrations of hydrochlorothiazide (HCT) and ramiprilate may directly cause CNS AEs such as headache ...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1159/000489999
データ提供:米国国立医学図書館(NLM)
Navigating the Brain: Pharmacokinetic Insights into CNS Adverse Effects
Drugs can cause central nervous system (CNS) adverse effects when they reach the CNS. This research investigates the pharmacokinetic (PK) profiles of hydrochlorothiazide (HCT) and ramiprilate, two medications commonly used to treat hypertension, to determine their potential for causing CNS AEs such as headache and drowsiness.
Exploring the CNS Penetration of HCT and Ramiprilate
The study assessed the PK profiles of HCT and ramiprilate in blood serum and cerebrospinal fluid (CSF), providing valuable information about their CNS penetration. The authors found that both medications reached detectable concentrations in the CSF, suggesting that they could potentially cause CNS AEs directly. This finding highlights the importance of considering CNS penetration when evaluating the safety profiles of drugs.
Understanding the Risks of CNS Adverse Effects
This research emphasizes the significance of understanding the PK profiles of medications to assess their potential for causing CNS AEs. The study's findings underscore the importance of careful monitoring for CNS AEs in patients receiving HCT and ramiprilate, particularly those with pre-existing CNS conditions. Further research is needed to elucidate the specific mechanisms by which these medications might induce CNS AEs.
Dr.Camel's Conclusion
Imagine the CNS as a vast desert with intricate pathways, where medications must navigate to reach their target areas. This research explores the journey of HCT and ramiprilate through this desert, highlighting their potential for causing unexpected “sandstorms” in the form of CNS AEs. The findings suggest that carefully mapping these pathways is crucial for ensuring the safe and effective use of medications, reminding us that understanding drug behavior is essential for optimal health.
Date :
- Date Completed 2018-11-27
- Date Revised 2018-11-27
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.